A method for screening probiotics that achieve antidepressant function through 5-hydroxytryptophan-related pathway based on cellular level
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JIANGNAN UNIV
- Publication Date
- 2022-02-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of probiotic screening, in particular to a cell-based screening method for probiotics that achieve antidepressant functions through 5-hydroxytryptophan-related pathways. Background technique
[0002] Depression, also known as depressive disorder, is characterized by significant and persistent depression as the main clinical feature. Currently, more than 350 million people worldwide suffer from depression, and it is estimated that by 2030, depression will rank first in the global disease burden. A large number of studies have shown that the occurrence of depression is related to the imbalance of monoamine neurotransmitters in the brain, mainly manifested as a decrease in the concentration of 5-hydroxytryptamine (5-HT) in the synaptic gap of the brain. The current treatment for depression mainly focuses on increasing the level of 5-HT in the brain, such as selective serotonin reuptake inhibitors (SSRIs), the ...